title: Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012.
abstract: Infections caused by multidrug-resistant and extensively drug-resistant Gram-negative bacilli are increasingly challenging to manage in hospitals and long term-care facilities worldwide. As the therapeutic options are limited, the International Society of Chemotherapy in collaboration with the Asia-Pacific Society of Clinical Microbiology and Immunology organised a consensus conference as part of the 13th Asia-Pacific Congress of Clinical Microbiology and Infection. A panel of international experts from Europe, the Americas and Asia were convened to discuss the issues of therapeutic options for the management of these difficult-to-treat pathogens.
authors.affiliation: National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore.
authors.forename: Paul Anantharajah
authors.initials: PA
authors.lastname: Tambyah
authors.affiliation: Infectious Diseases Unit, Hospital Carlos G. Durand, Buenos Aires, Argentina.
authors.forename: Gabriel Levy
authors.initials: GL
authors.lastname: Hara
authors.affiliation: First Department of Propaedeutic Medicine, Athens University School of Medicine, Athens, Greece.
authors.forename: George L
authors.initials: GL
authors.lastname: Daikos
authors.affiliation: Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece; Tufts University School of Medicine, Boston, MA, USA.
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Falagas
authors.affiliation: Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
authors.forename: Teresita
authors.initials: T
authors.lastname: Mazzei
authors.affiliation: Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
authors.forename: Johan W
authors.initials: JW
authors.lastname: Mouton
authors.affiliation: Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Novelli
authors.affiliation: The First Hospital of China Medical University, Shenyang, China.
authors.forename: Baiyi
authors.initials: B
authors.lastname: Chen
authors.affiliation: Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai 200040, China.
authors.forename: Minggui
authors.initials: M
authors.lastname: Wang
authors.affiliation: Department of Internal Medicine, National Cheng Kung University Medical College and Hospital, Taiwan.
authors.forename: Wen-Chien
authors.initials: WC
authors.lastname: Ko
authors.affiliation: Peking Union Medical College Hospital, Beijing, China.
authors.forename: Taisheng
authors.initials: T
authors.lastname: Li
authors.affiliation: West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
authors.forename: Xinjian
authors.initials: X
authors.lastname: Fan
authors.affiliation: Center for Anti-Infective Agents, Eckpergasse 13, 1180 Vienna, Austria. Electronic address: utheuretzbacher@cefaia.com.
authors.forename: Ursula
authors.initials: U
authors.lastname: Theuretzbacher
keywords: Aminoglycoside; Carbapenems; Colistin; Extensively drug-resistant; Gram-negative bacteria; Resistance; Tigecycline